AccurKardia Granted Patent for AI-Driven ECG Detection of Cardiac Amyloidosis
/
DateJun 02 2026
Patent establishes IP across all major amyloidosis subtypes and transforms the standard 12-lead ECG into a screening tool for one of cardiology’s most underdiagnosed diseases... Read More →


















